Please login to the form below

Not currently logged in
Email:
Password:

HER2 drugs

This page shows the latest HER2 drugs news and features for those working in and with pharma, biotech and healthcare.

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

The subcutaneous formulation of the two HER2-targeting drugs was equally as effective as giving Herceptin and Perjeta by intravenous (IV) infusion – the current route of administration – at achieving therapeutic levels ... This approval represents a

Latest news

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics